Middle East Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, ZFN), By Delivery Method (Ex Vivo. In Vivo), By Application, By Mode (Contract, In-house), By End Use, By Country, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology Segment
  • 1.2.2. Delivery Method Segment
  • 1.2.3. Application Segment
  • 1.2.4. Mode Segment
  • 1.2.5. End Use Segment
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Market Model
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Middle East Genome Editing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Widespread adoption of CRISPR technologies
    • 3.2.1.2. National genome programs boosting regional research
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Challenges concerning clinical translation
    • 3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
• 3.3. Middle East Genome Editing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Middle East Genome Editing Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Middle East Genome Editing Market Technology Movement Analysis
• 4.3. Middle East Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 4.4. (CRISPR)/Cas9
  • 4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. TALENs/MegaTALs
  • 4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. ZFN
  • 4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Meganuclease
  • 4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Middle East Genome Editing Market: Delivery Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Middle East Genome Editing Market Delivery Method Movement Analysis
• 5.3. Middle East Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
• 5.4. Ex Vivo
  • 5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. In Vivo
  • 5.5.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Middle East Genome Editing Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Middle East Genome Editing Market Application Movement Analysis
• 6.3. Middle East Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Genetic Engineering
  • 6.4.1. Genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.2. Cell Line Engineering
    • 6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.3. Animal Genetic Engineering
    • 6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.4. Plant Genetic Engineering
    • 6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.5. Others
    • 6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Clinical Applications
  • 6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Diagnostics Development
    • 6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. Therapy Development
    • 6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Middle East Genome Editing Market: Mode Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Middle East Genome Editing Market Mode Movement Analysis
• 7.3. Middle East Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
• 7.4. Contract
  • 7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. In-house
  • 7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Middle East Genome Editing Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Middle East Genome Editing Market End Use Movement Analysis
• 8.3. Middle East Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Biotechnology and Pharmaceutical Companies
  • 8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. Academic and Government Research Institutes
  • 8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Contract Research Organizations
  • 8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Middle East Genome Editing Market: Country Estimates & Trend Analysis

• 9.1. Country Market Share Analysis, 2024 & 2033
• 9.2. Country Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 9.4. Middle East
  • 9.4.1. Saudi Arabia
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory landscape
    • 9.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.2. UAE
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory landscape
    • 9.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.3. Kuwait
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory landscape
    • 9.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.4. Qatar
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory landscape
    • 9.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.5. Oman
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory landscape
    • 9.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.6. Rest of Middle East
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory landscape
    • 9.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. Merck KGaA
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Takara Bio Inc.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Revvity, Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Danaher Corporation
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. GenScript
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. New England Biolabs
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Charles River Laboratories
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Eurofins Scientific
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Lonza
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Thermo Fisher Scientific, Inc.
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Regulatory Framework
• Table 4 Middle East Genome editing Market, By country, 2021 - 2033 (USD Million)
• Table 5 Middle East Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 6 Middle East Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 7 Middle East Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 8 Middle East Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 9 Middle East Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 10 Saudi Arabia Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 11 Saudi Arabia Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 12 Saudi Arabia Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 13 Saudi Arabia Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 14 Saudi Arabia Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 15 UAE Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 16 UAE Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 17 UAE Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 18 UAE Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 19 UAE Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 20 Kuwait Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 21 Kuwait Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 22 Kuwait Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 23 Kuwait Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 24 Kuwait Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 25 Qatar Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 26 Qatar Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 27 Qatar Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 28 Qatar Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 29 Qatar Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 30 Oman Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 31 Oman Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 32 Oman Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 33 Oman Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 34 Oman Genome editing Market, By end use, 2021 - 2033 (USD Million)
• Table 35 Rest of Middle East Genome editing Market, By technology, 2021 - 2033 (USD Million)
• Table 36 Rest of Middle East Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
• Table 37 Rest of Middle East Genome editing Market, By applications, 2021 - 2033 (USD Million)
• Table 38 Rest of Middle East Genome editing Market, By mode, 2021 - 2033 (USD Million)
• Table 39 Rest of Middle East Genome editing Market, By end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Middle East genome editing market segmentation
• Fig. 2 Information procurement
• Fig. 3 Data analysis models
• Fig. 4 Market formulation and validation
• Fig. 5 Data validating & publishing
• Fig. 6 Market research process
• Fig. 7 Information procurement
• Fig. 8 Primary research
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Middle East genome editing market: Technology outlook key takeaways
• Fig. 13 Middle East genome editing market: Technology movement analysis
• Fig. 14 Middle East CRISPR/Cas9 market, 2021 - 2033 (USD Million)
• Fig. 15 Middle East ZFN market, 2021 - 2033 (USD Million)
• Fig. 16 Middle East meganuclease market, 2021 - 2033 (USD Million)
• Fig. 17 Middle East others market, 2021 - 2033 (USD Million)
• Fig. 18 Middle East genome editing market: Delivery Method outlook and key takeaways
• Fig. 19 Middle East genome editing market: Delivery Method movement analysis
• Fig. 20 Middle East ex vivo market, 2021 - 2033 (USD Million)
• Fig. 21 Middle East in vivo market, 2021 - 2033 (USD Million)
• Fig. 22 Middle East genome editing market: Application outlook and key takeaways
• Fig. 23 Middle East genome editing market: Application movement analysis
• Fig. 24 Middle East genetic engineering market, 2021 - 2033 (USD Million)
• Fig. 25 Middle East cell line engineering market, 2021 - 2033 (USD Million)
• Fig. 26 Middle East animal genetic engineering market, 2021 - 2033 (USD Million)
• Fig. 27 Middle East plant genetic engineering market, 2021 - 2033 (USD Million)
• Fig. 28 Middle East others market, 2021 - 2033 (USD Million)
• Fig. 29 Middle East clinical applications market, 2021 - 2033 (USD Million)
• Fig. 30 Middle East therapy development market, 2021 - 2033 (USD Million)
• Fig. 31 Middle East diagnostics development market, 2021 - 2033 (USD Million)
• Fig. 32 Middle East genome editing market: Mode outlook and key takeaways
• Fig. 33 Middle East genome editing market: Mode movement analysis
• Fig. 34 Middle East contract market, 2021 - 2033 (USD Million)
• Fig. 35 Middle East in-house market, 2021 - 2033 (USD Million)
• Fig. 36 Middle East genome editing market: End use outlook and key takeaways
• Fig. 37 Middle East genome editing market: End use movement analysis
• Fig. 38 Middle East biotechnology & pharmaceutical companies market, 2021 - 2033 (USD Million)
• Fig. 39 Middle East academic & research institutes market, 2021 - 2033 (USD Million)
• Fig. 40 Middle East contract research organizations market, 2021 - 2033 (USD Million)
• Fig. 41 Middle East genome editing market revenue, by country, 2022 & 2033 (USD Million)
• Fig. 42 Country marketplace outlook, 2024 & 2033 (USD Million)
• Fig. 43 Country marketplace: Key takeaways
• Fig. 44 Key country dynamics
• Fig. 45 Saudi Arabia genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 UAE genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Kuwait genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 Key Country Dynamics
• Fig. 51 Qatar genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Oman genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Rest of Middle East genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Market participant categorization
• Fig. 57 Strategic framework